SIA "Solepharm Pharmaceuticals"Active
Key figures
Ratios
2025Balance sheet structure
Summary of financial statements2011–2025
| 2011 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | ||||||||||||
| Total current assets | 2002 | 7895 | 1393 | 1535 | 1347 | 281 | 1343 | 564 | 978 | 2365 | 1097 | 4477 |
| Total non-current assets | 480 | 2310 | 1770 | 1230 | 690 | 150 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total assets | 2482 | 10 205 | 3163 | 2765 | 2037 | 431 | 1343 | 564 | 978 | 2365 | 1097 | 4477 |
| Balance sheet — liabilities and equity | ||||||||||||
| Current liabilities | 3273 | 5938 | 4361 | 2443 | 491 | 1221 | 1118 | 855 | 848 | 1096 | 1092 | 2839 |
| Non-current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | 3273 | 5938 | 4361 | 2443 | 491 | 1221 | 1118 | 855 | 848 | 1096 | 1092 | 2839 |
| Share capital | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — | — | — | — | — | — |
| Profit for the year | -792 | -321 | -5620 | 1520 | 1224 | -2337 | 1015 | -516 | 421 | 1139 | -1264 | 1634 |
| Total equity | -791 | 4267 | -1198 | 322 | 1546 | -790 | 225 | -291 | 130 | 1269 | 5 | 1638 |
| Income statement | ||||||||||||
| Sales revenue | 7255 | 38 637 | 35 648 | 20 598 | 6320 | 14 350 | 15 142 | 14 380 | 14 750 | 16 000 | 19 000 | 22 000 |
| Operating profit | -139 | 3156 | -5620 | 1520 | 1224 | -2337 | 1015 | -516 | 421 | -48 861 | -1264 | 1634 |
| Profit before income tax | -139 | 3156 | -5620 | 1520 | 1224 | -2337 | 1015 | -516 | 421 | 201 139 | 298 736 | 279 634 |
| Profit for the reporting year | -792 | -321 | -5620 | 1520 | 1224 | -2337 | 1015 | -516 | 421 | 1139 | -1264 | 1634 |
| Labour costs | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation of non-current assets | — | — | — | — | — | — | — | — | — | — | — | — |
| Other indicators | ||||||||||||
| Employees | 4 | 5 | 5 | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| Calculated dividend | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
Related companies
- SIA "Solepharm" — 100%
Summary: SIA "Solepharm Pharmaceuticals"
Overview
SIA "Solepharm Pharmaceuticals" (reg. no. 40103432050) is a limited liability company. The company was registered in 2011 and has been in the register for 15 years. Registered address: Mārupes nov., Mārupes pag., Jaunmārupe, Alkšņu iela 4.
Financial results
Revenue in 2025 was 22 000 €, up 15,8% on the previous year (19 000 €). From 2011 to 2025, revenue grew by an average of 10,6% per year. Net profit for 2025 was 1634 € (7,4% of revenue). The company was profitable in 6 of the 12 published years. In 2025 the company had 1 employees. Revenue per employee was 22 000 €. At the end of 2025, total assets were 4477 € and equity 1638 € (36,6% of assets).
Management and owners
The company has one board member. According to the register, the company has 2 owners. The largest stake (50%) is held by a private individual. The company holds a stake in one other active Latvian company.
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 02.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.